Guangdong Hybribio Biotech Co.,Ltd.’s Net Profit Rose 103.6% in 2022

Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) (300639.SZ) reported a net profit of 1.8 billion yuan in 2022, up 103.6% year-on-year.

Meanwhile, the company posted 5.6 billion yuan in revenue, up 109.4% year-on-year.

At the end of the reporting period, it had 6.7 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 22.4%.